Profilo
Mr. Thomas G.
Mechtersheimer is a Chief Executive Officer & Executive Director at neurocare group AG and a Founder at Passion Innovation Group Pty Ltd. He is on the Board of Directors at neurocare group AG.
Mr. Mechtersheimer was previously employed as a Non-Executive Director by Fresenius Kabi Oncology Ltd. and a President-Asia Pacific Region by Fresenius Kabi AG.
Posizioni attive di Thomas Mechtersheimer
| Società | Posizione | Inizio |
|---|---|---|
Passion Innovation Group Pty Ltd.
Passion Innovation Group Pty Ltd. Financial ConglomeratesFinance Provides investment services to the technology industry | Fondatore | 11/12/2013 |
neurocare group AG
neurocare group AG Packaged SoftwareTechnology Services Operates as a neuromodulation therapy platform to clinical and commercial outcomes | Fondatore | 01/01/2015 |
Precedenti posizioni note di Thomas Mechtersheimer
| Società | Posizione | Fine |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Direttore/Membro del Consiglio | - |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
Fresenius Kabi Oncology Ltd.
Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures and markets cancer research and anticancer products | Commercial Services |
Passion Innovation Group Pty Ltd.
Passion Innovation Group Pty Ltd. Financial ConglomeratesFinance Provides investment services to the technology industry | Finance |
neurocare group AG
neurocare group AG Packaged SoftwareTechnology Services Operates as a neuromodulation therapy platform to clinical and commercial outcomes | Technology Services |
















